Home LiteratureArticle Details
PMID: 6792907 Published · ppublish English Journal Article

Hyperalimentation-induced cholestasis. Increased incidence and severity in premature infants.

American journal of diseases of children (1960) ·Vol. 135 ·No. 9 ·1981-09-00 ·Pages 842-5

Pereira GR, Sherman MS, DiGiacomo J, Ziegler M, Roth K, Jacobowski D

Abstract

Two hundren sixty-seven neonates who received parenteral nutrition were monitored for signs of liver dysfunction. Cholestatic jaundice occurred in we infants, with a higher incidence in the more immature infants. There was an inverse correlation between severity of jaundice and the degree of prematurity. Infants with cholestasis remained without gastrointestinal feedings and received parenteral nutrition for periods of time significantly higher than infants without cholestasis. The incidence of this complication did not seem to correlate with the amount of protein infusate (amino acid solution). A higher incidence of sepsis was noted in infants who were affected by cholestasis. Close monitoring for signs of liver dysfunction in all neonates receiving parenteral nutrition is strongly recommended.

MeSH Terms
Bilirubin/blood Cholestasis/etiology Gestational Age Humans Infant, Newborn Infant, Premature, Diseases/etiology Parenteral Nutrition/adverse effects Parenteral Nutrition, Total/adverse effects
Chemicals
Bilirubin
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Pereira G R
Sherman M S
DiGiacomo J
Ziegler M
Roth K
Jacobowski D
Article Info
Journal
American journal of diseases of children (1960)
Abbr.
Am J Dis Child
ISSN
0002-922X
Published
1981-09-00
Pages
842-5
Language
English
Region
United States
NLM ID
0370471
Subset
IM
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com